Treace Medical Surprised by 3Q Seasonality
The company grew more than 23% in 3Q23 but ultimately reduced its guidance because of higher-than-expected seasonality during the summer. Nov 14, 2023
Bioventus OA Pain Business Returns to Growth Ahead of Schedule
The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume offset price declines. Nov 14, 2023
Enovis on Cusp of $1 Billion Recon Business
The company's orthopedic sales grew in the mid-teens during the third quarter of 2023, as it continues to win market share from peers. Nov 09, 2023
Zimmer Biomet Confident in Sustained Growth Momentum
The company grew in the mid-single-digits in the third quarter of 2023, driven by knee replacement and its SET product category. Nov 08, 2023
Globus Medical Encouraged by Early Integration Efforts
The company grew more than 50% in the third quarter of 2023 as it benefit from continued share growth and a month of NuVasive sales. Nov 08, 2023
ATEC Prepared to Leverage Unique Opportunity
The company grew more than 40% in the third quarter of 2023 as it procedural solutions continue winning significant market share. Nov 07, 2023
SI-BONE Maintains Record Revenue Pace
The company grew nearly 29% in the third quarter of 2023, notching its sixth consecutive quarter of record revenues. Nov 07, 2023
Smith+Nephew Finally Taps Into Market Upside
The company grew in the high-single-digits in the third quarter of 2023, driven by market recovery and improving operational performance. Nov 06, 2023
Anika Therapeutics Ready to Build on 2023 Milestones
The company grew in the mid-single-digits for the third quarter of 2023, driven by new products and better-than-expected orthobiologics sales. Nov 06, 2023
Stryker’s Model Drives Best-in-Class Performance
The company grew in the high-single-digits in the third quarter of 2023, driven by new products and robotic procedures. Nov 03, 2023
